IN8BIO
Dead / Abandoned — Abandoned — failure to respond (as of 13 Dec 2021)
What this means for you
This application is over — abandoned 26 Nov 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90099348
- Mark type
- Stylized text
- Filed
- 07 Aug 2020
- Abandoned
- 26 Nov 2021
- Attorney of record
- Mark Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, oncological preparations; Reagent, diagnostic and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression
- Class 042 — Scientific and technological services: Research, development, and evaluation of new products; Pharmaceutical, medicine, and vaccine research and development services; Technical research in the field of pharmaceutical studies; Laboratory analysis and research into new drugs and pharmaceutical products; Development of scientific measuring and testing methods in the field of oncology; Design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; Research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; Providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; Scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology
- Class 044 — Medical, beauty and agricultural services: Development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment
Owner
- IN8BIO, INC., NEW YORK, NY, US
- Incysus Therapeutics, Inc., New York, NY, US
Prosecution history
- 13 Dec 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 13 Dec 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 24 May 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 24 May 2021 — FINAL REFUSAL E-MAILED
- 24 May 2021 — FINAL REFUSAL WRITTEN
- 29 Apr 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Apr 2021 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 21 Apr 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Apr 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Oct 2020 — NON-FINAL ACTION E-MAILED
- 20 Oct 2020 — NON-FINAL ACTION WRITTEN
- 20 Oct 2020 — ASSIGNED TO EXAMINER
- 08 Sept 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED